Bupropion hydrochloride
- Product NDC
- 58657-713
- 11-digit product format
- 586570713
- Labeler code
- 58657
- Product ID
- 58657-713_edb47931-e2a7-4ee7-e053-2995a90a40b9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Method Pharmaceuticals, LLC
- Application
- ANDA211020
- Marketing category
- ANDA
- Marketing start
- 2019-01-28
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 58657-713-30 | 58657071330 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (58657-713-30) | 2019-01-28 | 0000-00-00 | No | No | Current |
| 58657-713-50 | 58657071350 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (58657-713-50) | 2019-01-28 | 0000-00-00 | No | No | Current |
| 58657-713-90 | 58657071390 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (58657-713-90) | 2019-01-28 | 0000-00-00 | No | No | Current |